Choose HA†
Prescribing Information   |  OAKneePainRelief.com
OAGeneral-header-assessment

Talk to Your Doctor About Osteoarthritis

Find a Physician

Which therapy will work best for you?

The answer depends on many factors, including your health, other medications you take, and whether your osteoarthritis case is mild, moderate or severe. The earlier you and your doctor work together, the sooner you can begin a treatment plan that is right for you.

Using the osteoarthritis self-assessment tool below can help you prepare to discuss your symptoms.

Assesment tool

1. How long have you been experiencing knee pain?

1. How long have you been experiencing knee pain?

2. Have you recently injured your knee?

2. Have you recently injured your knee?

3. How would you rate your knee pain on a scale of 1 (no pain) to 10 (unbearable pain) when resting?

(1 = No pain)(10 = The worst pain imaginable)

4. How would you rate your knee pain on a scale of 1 (no pain) to 10 (unbearable pain) with activity?

(1 = No pain)(10 = The worst pain imaginable)

5. What daily activities are more difficult due to your knee pain? Check all that apply.

6. What treatments have you tried to help with your knee pain? Check all that apply.

7. Has your knee ever become swollen or enlarged? If yes, how often?

8. Have you been diagnosed with osteoarthritis (OA) of the knee by a doctor or other healthcare professional?

9. What are your goals and expectations from treatment?

Download Assessment
2.3-square-iStock-1131359229

DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

DUROLANE has not been tested in pregnant or lactating women, or children.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.